BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21849525)

  • 1. Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma.
    Wu ZS; Yang K; Wan Y; Qian PX; Perry JK; Chiesa J; Mertani HC; Zhu T; Lobie PE
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1619-29. PubMed ID: 21849525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human growth hormone and human prolactin function as autocrine/paracrine promoters of progression of hepatocellular carcinoma.
    Kong X; Wu W; Yuan Y; Pandey V; Wu Z; Lu X; Zhang W; Chen Y; Wu M; Zhang M; Li G; Tan S; Qian P; Perry JK; Lobie PE; Zhu T
    Oncotarget; 2016 May; 7(20):29465-79. PubMed ID: 27102295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine human GH promotes radioresistance in mammary and endometrial carcinoma cells.
    Bougen NM; Steiner M; Pertziger M; Banerjee A; Brunet-Dunand SE; Zhu T; Lobie PE; Perry JK
    Endocr Relat Cancer; 2012 Oct; 19(5):625-44. PubMed ID: 22807498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocrine human growth hormone reduces mammary and endometrial carcinoma cell sensitivity to mitomycin C.
    Bougen NM; Yang T; Chen H; Lobie PE; Perry JK
    Oncol Rep; 2011 Aug; 26(2):487-93. PubMed ID: 21567106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
    Trovik J; Wik E; Werner HM; Krakstad C; Helland H; Vandenput I; Njolstad TS; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; ; Amant F; Akslen LA; Salvesen HB
    Eur J Cancer; 2013 Nov; 49(16):3431-41. PubMed ID: 23932335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of ERK1/2 occurs independently of KRAS or BRAF status in endometrial cancer and is associated with favorable prognosis.
    Mizumoto Y; Kyo S; Mori N; Sakaguchi J; Ohno S; Maida Y; Hashimoto M; Takakura M; Inoue M
    Cancer Sci; 2007 May; 98(5):652-8. PubMed ID: 17388789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Ret finger protein correlates with outcomes in endometrial cancer.
    Tsukamoto H; Kato T; Enomoto A; Nakamura N; Shimono Y; Jijiwa M; Asai N; Murakumo Y; Shibata K; Kikkawa F; Takahashi M
    Cancer Sci; 2009 Oct; 100(10):1895-901. PubMed ID: 19650860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The testis as eutopic production site of human growth hormone, placental lactogen and prolactin: possible autocrine/paracrine effects on testicular function].
    Untergasser G; Kranewitter W; Walser F; Madersbacher S; Dirnhofer S; Berger P
    Wien Klin Wochenschr; 1996; 108(17):541-6. PubMed ID: 8992787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated macrophages, epidermal growth factor receptor correlated with the triple negative phenotype in endometrial endometrioid adenocarcinoma.
    Jiang XF; Tang QL; Shen XM; Li HG; Chen LH; Wang XY; Luo X; Lin ZQ; Jiang GY
    Pathol Res Pract; 2012 Dec; 208(12):730-5. PubMed ID: 23122929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine proliferative effects of hGH are maintained in primary cultures of human mammary carcinoma cells.
    Chiesa J; Ferrer C; Arnould C; Vouyovitch CM; Diaz JJ; Gonzalez S; Mares P; Morel G; Wu ZS; Zhu T; Lobie PE; Mertani HC
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1418-26. PubMed ID: 21733992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine human growth hormone promotes tumor angiogenesis in mammary carcinoma.
    Brunet-Dunand SE; Vouyovitch C; Araneda S; Pandey V; Vidal LJ; Print C; Mertani HC; Lobie PE; Perry JK
    Endocrinology; 2009 Mar; 150(3):1341-52. PubMed ID: 18974274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The frequency and significance of WT-1 expression in serous endometrial carcinoma.
    Hedley C; Sriraksa R; Showeil R; Van Noorden S; El-Bahrawy M
    Hum Pathol; 2014 Sep; 45(9):1879-84. PubMed ID: 25033726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative disorders of the aging human prostate: involvement of protein hormones and their receptors.
    Untergasser G; Rumpold H; Hermann M; Dirnhofer S; Jilg G; Berger P
    Exp Gerontol; 1999 Apr; 34(2):275-87. PubMed ID: 10363793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
    Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
    Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
    Zhang G; Li XP; Wang JL; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine Prolactin Stimulates Endometrial Carcinoma Growth and Metastasis and Reduces Sensitivity to Chemotherapy.
    Ding K; Yuan Y; Chong QY; Yang Y; Li R; Li X; Kong X; Qian P; Xiong Z; Pandey V; Ma L; Wu Z; Lobie PE; Zhu T
    Endocrinology; 2017 Jun; 158(6):1595-1611. PubMed ID: 28204229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis.
    Zekri A; Ghaffari SH; Yousefi M; Ghanizadeh-Vesali S; Mojarrad M; Alimoghaddam K; Ghavamzadeh A
    Mol Cell Endocrinol; 2013 Sep; 377(1-2):84-92. PubMed ID: 23851143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
    Salvesen HB; Iversen OE; Akslen LA
    Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of human growth hormone and prolactin secreted in vitro: Immunoassay and radioreceptor assay correlations.
    Guyda JH
    J Clin Endocrinol Metab; 1975 Nov; 41(5):953-67. PubMed ID: 1184726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome.
    Ferrandina G; Legge F; Ranelletti FO; Zannoni GF; Maggiano N; Evangelisti A; Mancuso S; Scambia G; Lauriola L
    Cancer; 2002 Aug; 95(4):801-7. PubMed ID: 12209724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.